Off-label treatment in diabetic retinopathy

Auteurs

  • Luis Jesuino de Oliveira Andrade Universidade Estadual de Santa Cruz
  • Larissa Santos França Hospital Calixto Midlej Filho - Itabuna - Bahia.
  • Luciana Santos França Hospital Calixto Midlej filho - Itabuna - Bahia.
  • Alcina Maria Vinhaes Bittencourt Faculdade de Medicina - Universidade Federal da Bahia.
  • Caroline Santos França Hospital São Rafael - Salvador - Bahia

DOI :

https://doi.org/10.9771/cmbio.v13i1.9024

Mots-clés :

Diabetic retinopathy. Off-label use. Therapy. Diabetes mellitus.

Résumé

Introduction: The prescribing a drug without the indications for which the drug was originally approved by regulators is internationally known as prescribing “off-label”. Objective: To describe the off-label therapy in diabetic retinopathy, reported international scientific literature, through an integrative bibliographical review. Method: Integrative review by searching the Medline international database for review of manuscripts. Results: A total 852 scientific productions were identified, and 37 studies were selected by contain information about the off-label therapy in diabetic retinopathy. Conclusion: The practice of off-label prescribing in diabetic retinopathy has benefits, and in some situations is the only treatment available.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Téléchargements

Publiée

2014-07-21

Comment citer

de Oliveira Andrade, L. J., Santos França, L., Santos França, L., Vinhaes Bittencourt, A. M., & Santos França, C. (2014). Off-label treatment in diabetic retinopathy. Revista De Ciências Médicas E Biológicas, 13(1), 78–84. https://doi.org/10.9771/cmbio.v13i1.9024

Numéro

Vol. 13 No 1 (2014): REVISTA DE CIÊNCIAS MÉDICAS E BIOLÓGICAS

Rubrique

Artigos de revisão

Licence

A Revista de Ciências Médicas e Biológicas reserva-se todos os direitos autorais dos trabalhos publicados, inclusive de tradução, permitindo, entretanto, a sua posterior reprodução como transcrição, com a devida citação de fonte. O periódico tem acesso livre e gratuito.

 

 

Articles les plus lus par le même auteur ou la même autrice

1 2 > >>